PF-06648671

CAS No. 1587727-31-8

PF-06648671( PF6648671 )

Catalog No. M12266 CAS No. 1587727-31-8

PF-06648671 (PF6648671) is a novel oral γ-secretase modulator being developed for the treatment of Alzheimer's disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 896 In Stock
50MG 3222 In Stock
100MG 4410 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PF-06648671
  • Note
    Research use only, not for human use.
  • Brief Description
    PF-06648671 (PF6648671) is a novel oral γ-secretase modulator being developed for the treatment of Alzheimer's disease.
  • Description
    PF-06648671 (PF6648671) is a novel oral γ-secretase modulator being developed for the treatment of Alzheimer's disease.Alzheimer Disease Phase 1 Discontinued.
  • In Vitro
    In a cell-based assay, PF-06648671 reduces Aβ42 and Aβ40 , with concomitant increases in Aβ37 and Aβ38, without inhibiting the cleavage of Notch or other substrates.
  • In Vivo
    PF-06648671 demonstrates reduces Aβ42 within the brain and CSF following acute oral administration in animals.
  • Synonyms
    PF6648671
  • Pathway
    Wnt/Notch/Hedgehog
  • Target
    γ-secretase
  • Recptor
    γ-secretase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1587727-31-8
  • Formula Weight
    538.928
  • Molecular Formula
    C25H23ClF4N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C(N2CCN1[C@H]([C@H]3O[C@@H](C4=CC(F)=C(Cl)C=C4C(F)(F)F)CC3)C)=CC=C(N5C=C(C)N=C5)C2=O
  • Chemical Name
    2H-Pyrido[1,2-a]pyrazine-1,6-dione, 2-[(1S)-1-[(2S,5R)-5-[4-chloro-5-fluoro-2-(trifluoromethyl)phenyl]tetrahydro-2-furanyl]ethyl]-3,4-dihydro-7-(4-methyl-1H-imidazol-1-yl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • RO4929097

    RO4929097 (RG 4733) is a potent, selective, orally active γ-secretase inhibitor with IC50 of 4 nM.

  • BMS-708163

    A potent, selective and orally bioavailable inhibitor of γ-secretase with Aβ40 IC50 of 3.0 nM.

  • MRK-003

    A potent γ-secretase inhibitor with IC50 of 0.4 nM, inhibition of Aβ secretion from SH-SY5Y SPA4CT cells.